The following is selected financial information for D. Kay Dental Laboratories for 2023 and 2024: 2023 2024 Retained earnings, January 1 $ 62,000 ?question mark Net income 46,000 51,000 Dividends declared and paid 24,000 27,000 Common stock 79,000 ?question mark Kay issued 2,900 shares of additional common stock in 2024 for $29,000. There were no other shareholder transactions.

Prepare a statement of shareholders' equity for D. Kay Dental Laboratories for the year ended December 31, 2024.